Physician profile
Paul A Jackson
NPI 1093738536
$5,551.04
in general payments reported to CMS, 2019-2025
34 companies · $818 in 2025
The $818 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,151 · 2020: $681 · 2021: $811 · 2022: $678 · 2023: $658 · 2024: $753 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,151 · Education: $64.54 · Entertainment: $13.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,150.83 |
| Education | $64.54 |
| Entertainment | $13.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $971.88 | 2019-2025 | Repatha, Repatha, Corlanor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $638.57 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $547.74 | 2019-2024 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $466.87 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $449.36 | 2019-2025 | |
| Novo Nordisk INC | $347.23 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $287.71 | 2019-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $264.82 | 2019-2022 | |
| Edwards Lifesciences Corporation | $176.45 | 2022-2025 | |
| Abbott Laboratories | $176.18 | 2019-2024 | Jot Dx, Assurity |
| Pfizer INC. | $158.22 | 2019-2023 | |
| Amarin Pharma, INC. | $129.13 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.49 | 2021-2023 | Jardiance |
| Medtronic, INC. | $88.09 | 2022-2025 | Linq II, Mycarelink |
| Lundbeck LLC | $75.82 | 2019-2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $74.95 | 2024 | Arcalyst |
| E.R. Squibb & Sons, L.L.C. | $72.13 | 2019-2023 | Eliquis |
| Philips North America LLC | $68.19 | 2020 | |
| Arbor Pharmaceuticals, INC. | $65.71 | 2019-2021 | |
| Bardy Diagnostics, INC. | $52.00 | 2020 | |
| Preventice Services, LLC | $36.16 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $36.11 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $33.47 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $27.90 | 2024 | Onpattro |
| Ge Healthcare | $24.90 | 2025 | |
| Abiomed | $24.34 | 2024 | Impella |
| Baxter Healthcare | $21.25 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Dexcom, INC. | $20.94 | 2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $20.74 | 2025 | |
| Lilly USA, LLC | $19.39 | 2025 | Zepbound, Mounjaro |
| Recor Medical INC | $19.24 | 2025 | Paradise Ultrasound Renal Denervation System |
| Esperion Therapeutics, INC. | $17.55 | 2020 | |
| Ethicon US, LLC | $15.72 | 2019 | |
| Optos, INC. | $13.79 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.